ERA Protocol Webinar Series
Dr. Tiffany Stankewicz
Endometrio Product Director
Igenomix
Proper protocol compliance to optimize your clinic’s ERA outcomes
500
SCIENTIFIC
PUBLICATIONS
20
LABS
WORLDWIDE
++600
PROFESSIONALS
+4
PATENTS
Igenomix offers pioneering tests to help reproductive health professionals diagnose and treat their patients.
Detect genetic changes in the egg source or sperm source before conception so you can explore about options to have a healthy baby
More informationHelp reduce the risk for implantation failure or miscarriage and improve the chances for a healthy pregnancy
More informationUnderstand whether a pregnancy is at an increased risk for a genetic syndrome
More informationIgenomix is a medical testing laboratory specializing in reproductive genetic services founded in 2011.
We work to make a world in which infertility is no longer an impossible barrier. Together with clinics and fertility doctors worldwide, we investigate human reproduction to change the lives of couples who are trying to conceive.
In 2021, Vitrolife acquired Igenomix. Together we create Vitrolife Group, a global leader in reproductive health. By combining Igenomix’s portfolio of reproductive genetic testing services with Vitrolife’s best-in-class IVF device portfolio, we support clinics and patients across the fertility journey.
Learn more about Igenomix